Stay updated on Tavo in TNBC Clinical Trial
Sign up to get notified when there's something new on the Tavo in TNBC Clinical Trial page.

Latest updates to the Tavo in TNBC Clinical Trial page
- CheckyesterdayChange DetectedThe page has updated the status of a project to 'Unknown' and removed the previous status of 'Active, not recruiting'.SummaryDifference0.6%
- Check8 days agoChange DetectedThe web page has been updated from version 2.15.0 to version 2.15.2.SummaryDifference0.1%
- Check15 days agoNo Change Detected
- Check22 days agoChange DetectedThe webpage has been updated to reflect a new study on Triple Negative Breast Cancer (TNBC) involving the drug nab-paclitaxel and gemcitabine plus carboplatin, with a focus on a Phase 2, Multi-Cohort, Open-Label study led by Merck Sharp & Dohme LLC. The previous version's detailed study description has been significantly condensed, removing specific cohort details and treatment regimens.SummaryDifference49%
- Check30 days agoChange DetectedThe web page has been updated from version 2.14.3 to version 2.14.4.SummaryDifference0.1%
- Check37 days agoChange DetectedThe web page has been updated from version 2.14.2 to version 2.14.3.SummaryDifference0.1%
- Check73 days agoChange DetectedThe page has removed a notice regarding heavy traffic affecting the performance and availability of some NLM-NCBI services and products.SummaryDifference1%
Stay in the know with updates to Tavo in TNBC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Tavo in TNBC Clinical Trial page.